Alleviating effects of Si-Ni-San, a traditional Chinese prescription, on experimental liver injury and its mechanisms

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 8, 2003, Pages 1089-1094

  Jiang, Jieyun ^a   Zhou, Chunxiang ^a   Xu, Qiang ^a,b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Alleviating effect; Apoptosis; Experimental liver injury; Hepatocyte membrane; Nitric oxide; Si Ni San

Indexed keywords

AMINOTRANSFERASE; BCG VACCINE; BUPLEURUM CHINENSE EXTRACT; CHLORINE DERIVATIVE; CITRUS AURANTIUM EXTRACT; CONCANAVALIN A; GLYCYRRHIZA URALENSIS EXTRACT; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PAEONIA ALBIFLORA EXTRACT; PICRYL CHLORIDE; PLANT EXTRACT; UNCLASSIFIED DRUG; CARBON TETRACHLORIDE; HERBACEOUS AGENT;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BUPLEURUM CHINENSE; CELL MEMBRANE; CHINESE MEDICINE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; GLYCYRRHIZA URALENSIS; HEPATITIS; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MACROPHAGE; MEDICINAL PLANT; NONHUMAN; PAEONIA ALBIFLORA; PRESCRIPTION; SOUR ORANGE; SPLEEN CELL; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; LIVER DISEASE; METABOLISM; METHODOLOGY; MOUSE;

ANIMALS; CARBON TETRACHLORIDE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; LIVER DISEASES; MEDICINE, CHINESE TRADITIONAL; MICE;

EID: 2142711534     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.1089     Document Type: Article

References (24)

1. Ren H., Hubei J Trad. Chin. Med., 14, 55 (1992).
2. Chen J., J. Trad. Chin. Med., 27, 13-15 (1986).
3. Chen R., Sichuang J. Trad. Chin. Med., 4, 13 (1986).
4. Li Q., Qi Y., Gong C., Yi C., Pharmacol & Clinic. Chin. Mat. Med., 6, 10-12 (1992).
5. Xu Q., Wang R., Jiang J., Wu F., Lu J., Tan P. K., Xu L., Cell. Immunol., 167, 38-43 (1996).
6. Xu Q., Jiang J., Cao J., Wu F , Fujii H., Saiki I., Life Sci., 62, 1281-1292 (1998).
7. Neuschwander-Tetri B. A., Postgrad. Med., 98, 49-63 (1995).
8. Stuehr D. J., Gross S. S., Sakuma I., Levi R., Nathan C. F., J. Exp. Med., 169, 1011-1020 (1989).
9. Sellias K., Cohen J. J., J. Immunol., 139, 3199-3206 (1987).
10. Emlen W., Niebar J., Kadera R., J. Immunol., 152, 3685-3692 (1994).
11. Yamada T., "Biomanual up Series: Current Protocol in Apoptosis," Yodosha, Tokyo, 1995, pp. 61-67.
12. Xu Q., Wang R., Xu L., Chin. J. Immunol., 9, 287-290 (1993).
13. Xu Q., Lu J., Wang R., Wu F., Cao J., Chen X., Pharmacol. Res , 35, 273-278 (1997).
14. Xu Q., Yuan K., Lu J., Wang R., Wu F., Pharmacol. Res., 36, 401-409 (1997).
15. Wang G., Liu G., Biochem. Pharmacol., 49, 1277-1281 (1995)
16. Cao J., Xu Q., Koda A., Inflamm. Res., 49, 578-583 (2000).
17. Volpes R., van den Oord J. J., Desmet V. J., Hepatology, 13, 826-829 (1991).
18. Chisari F. V., Ferrari C , Ann. Rev. Immunol , 13, 29-60 (1995).
19. Diepolder H. M., Zachoval R., Hoffmann R. M., Jung M. C., Gerlach T., Pape G. R., J Mol. Med., 74, 583-588 (1996).
20. Lohr H. F., Schlaak J. F., Kollmannsperger S., Dienes H. P., Meyer zum Buschenfelde K. H., Gerken G., Liver, 16, 174-182 (1996).
21. Sun Y., Chen T., Xu Q., J. Pharm. Pharmacol., in press (2003).
22. Zhou C., Xu Q., Cao J., Jiang J., Wu F., Wang L., Zhang X., Chin. J. Bas. Med. Trad Chin. Med , 8, 367-369 (2002).
23. Singer G. G., Abbas A. K., Immunity, 1, 365-371 (1994).
24. Surh C. D., Sprent J., Nature (London), 372, 100-103 (1994).